Literature DB >> 16005619

Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice.

Monjed Shakweh1, Madeleine Besnard, Valérie Nicolas, Elias Fattal.   

Abstract

Nano-and microparticles of poly(lactide-co-glycolide) (PLGA) were formulated using poly(vinyl alcohol) (PVA) or hydrophobically modified hydroxyethylcellulose (HMHEC) or polyethyleneimine (PEI) as stabilizers. The uptake by murine Peyer's patches (PPs) and the binding to Peyer's patches-free tissue (PPFT) of these particles was investigated using fluorescence microscopy providing qualitative information about the tissue distribution of particles. Observations of intestinal cryo-sections showed significant discrimination in the uptake by PP of nano-and microparticles. The uptake by PPs of PLGA-PVA and PLGA-HMHEC nano-and microparticles, of negative and neutral zeta potential, respectively, was comparable, whereas a smaller number was observed in the case of nano-and microparticles of PLGA-PEI, positively charged. Moreover, particle uptake by PPs appeared to be strongly size-dependent. The number of particles of mean diameter around 0.3 and 1 microm observed in PPs was much greater than that of particles of diameter average close to 3 microm. However, in all cases, particles were found in the PPFT for at least 48 h. In conclusion, regarding the tissue samples we have observed, it appeared that the uptake of particles by PPs and binding to PPFT could be influenced by the physicochemical properties of the particles but this may not have been true at all sites of the intestine and may differ between animals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005619     DOI: 10.1016/j.ejpb.2005.04.006

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  21 in total

1.  Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin.

Authors:  Malgorzata S Cartiera; Elisa C Ferreira; Christina Caputo; Marie E Egan; Michael J Caplan; W Mark Saltzman
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

Review 2.  Recent advances in oral vaccine development: yeast-derived β-glucan particles.

Authors:  Rebecca De Smet; Liesbeth Allais; Claude A Cuvelier
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

3.  Sustained release of hydrophobic drugs by the microfluidic assembly of multistage microgel/poly (lactic-co-glycolic acid) nanoparticle composites.

Authors:  Myat Noe Hsu; Rongcong Luo; Kerwin Zeming Kwek; Yong Chen Por; Yong Zhang; Chia-Hung Chen
Journal:  Biomicrofluidics       Date:  2015-03-24       Impact factor: 2.800

4.  Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration.

Authors:  Ryan Gene Soderquist; Evan M Sloane; Lisa C Loram; Jacqueline A Harrison; Ellen C Dengler; Scott M Johnson; Luke D Amer; Courtney S Young; Makenzie T Lewis; Stephen Poole; Matthew G Frank; Linda R Watkins; Erin D Milligan; Melissa J Mahoney
Journal:  Pharm Res       Date:  2010-03-12       Impact factor: 4.200

5.  Evidence of oral translocation of anionic G6.5 dendrimers in mice.

Authors:  Giridhar Thiagarajan; Shraddha Sadekar; Khaled Greish; Abhijit Ray; Hamidreza Ghandehari
Journal:  Mol Pharm       Date:  2013-01-25       Impact factor: 4.939

6.  Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery.

Authors:  Thejani E Rajapaksa; Mary Stover-Hamer; Xiomara Fernandez; Holly A Eckelhoefer; David D Lo
Journal:  J Control Release       Date:  2009-11-05       Impact factor: 9.776

Review 7.  Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticles.

Authors:  Ashaben Patel; Mitesh Patel; Xiaoyan Yang; Ashim K Mitra
Journal:  Protein Pept Lett       Date:  2014       Impact factor: 1.890

8.  PEG-lipid-PLGA hybrid nanoparticles loaded with berberine-phospholipid complex to facilitate the oral delivery efficiency.

Authors:  Fei Yu; Mingtao Ao; Xiao Zheng; Nini Li; Junjie Xia; Yang Li; Donghui Li; Zhenqing Hou; Zhongquan Qi; Xiao Dong Chen
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 9.  Use of lectin-functionalized particles for oral immunotherapy.

Authors:  Susanne C Diesner; Xue-Yan Wang; Erika Jensen-Jarolim; Eva Untersmayr; Franz Gabor
Journal:  Ther Deliv       Date:  2012-02

10.  Plant extract synthesized PLA nanoparticles for controlled and sustained release of quercetin: a green approach.

Authors:  Avnesh Kumari; Vineet Kumar; Sudesh Kumar Yadav
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.